Facebook
Twitter
LinkedIn
ForwardRapid Clinical Updates: Hospitalist Management of Opioid Use Disorder
Summary
U.S. drug-related overdose deaths continue rising, with more than 100,000 individuals dying in the 12-month period ending in April 2021. Amidst this, hospitalists must be first-line responders in being able to assess and diagnose opioid use disorder, while offering evidence-based treatment. Participants will leave this session empowered to provide life-saving treatment for hospitalized patients with opioid use disorder.
This session is moderated by Joseph Sweigart, MD, FHM, SFHM. Our panelists include Marlene Martin, MD and Susan Calcaterra, MD, MPH
Target Audience
This activity is designed for hospitalists. No prerequisites required.
Accreditation Statement
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Statement Designation
The Society of Hospital Medicine designates this enduring internet activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM.
Release Date: January 27, 2022
Expiration Date: January 27, 2025
Estimated time to complete: 1 hour
Conflict of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.
Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.
Off Label Product Discussion
All faculty have indicated that they have not referenced unlabeled or unapproved uses of drugs or devices.
Additional Information
| Attachment | Size |
|---|---|
 Hospitalist Management of OUD Handout | 163 KB |
| Hospitalist Management of OUD Slides | 1.78 MB |
| X-Waiver FAQs.pdf | 161.67 KB |
The planners and faculty of this activity have no relevant financial relationships to disclose unless stated below.
SHM CONFLICT OF INTEREST DISCLOSURE POLICY
In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.
Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.
The Society of Hospital Medicine designates this enduring internet activity for a maximum of 1 AMA PRA Category 1 Credit™.
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provider continuing medical education for physicians.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-physician